Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on April 10, 2008
Chest, doi:10.1378/chest.07-2933
doi:10.1378/chest.07-2933
(Chest. 2008; 134:46-53)
© 2008 American College of Chest Physicians
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
chest.07-2933v1
134/1/46    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Benfield, T.
Right arrow Articles by Vestbo, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benfield, T.
Right arrow Articles by Vestbo, J.

COPD Stage and Risk of Hospitalization for Infectious Disease*

Thomas Benfield, MD, DMSc; Peter Lange, MD, DMSc and Jørgen Vestbo, MD, DMSc

* From the Departments of Infectious Diseases (Dr. Benfield), and Cardiology and Respiratory Medicine (Dr. Vestbo), Hvidovre University Hospital; and The Copenhagen City Heart Study (Dr. Lange), Bispebjerg University Hospital, Copenhagen, Denmark.

Correspondence to: Thomas Benfield, MD, DMSc, Department of Infectious Diseases 144, Hvidovre University Hospital, DK-2650 Hvidovre, Denmark; e-mail: tlb{at}dadlnet.dk

Abstract

Background: Respiratory tract infections are a frequent complication of COPD, but little is known about the incidence, association, and risk of infectious diseases related to impaired lung function.

Methods: Participants in the Copenhagen City Heart Study had lung function measured at baseline, and were followed for up to 25 years. All hospitalizations due to any infection were identified through registry linkage. Impaired lung function was defined according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging system.

Main results: A total of 3,333 infectious disease hospitalizations (IDHs) occurred during 230,653 person-years of follow-up (PY), corresponding to an overall incidence of 145 IDHs (95% confidence interval [CI], 139 to 149) per 10,000 PY. The incidence increased with GOLD stage, from 131 (95% CI, 126 to 136) for normal COPD, to 170 (95% CI, 146 to 193) for mild COPD, to 230 (95% CI, 207 to 253) for moderate COPD, and 394 (95% CI, 330 to 459) for severe/very severe COPD. The trend in risk persisted after the control of background characteristics using Cox proportional hazards analysis (adjusted relative risks: 1.06 [95% CI, 0.92 to 1.23], 1.39 [95% CI, 1.24 to 1.56], and 2.21 [95% CI, 1.84 to 2.64], respectively; p = 0.001). In subgroup analysis, the increased risk was associated with lower and upper respiratory tract infections, pyothorax, and tuberculosis, but not with influenza, sepsis, skin infections, urinary tract infections, diarrheal disease, or other infectious diseases.

Conclusions: The presence of obstructive lung disease is a significant predictor of IDH caused by respiratory tract infections, but not of hospitalizations due to infections outside the respiratory system.

Key Words: COPD • epidemiology • hospitalization • infection • lung function







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American College of Chest Physicians.